Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Laboratory Diagnosis of Coronavirus Disease-2019 (COVID-19)
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Laboratory Diagnosis of Coronavirus Disease-2019 (COVID-19)
Creator
Wang, Yunfeng
Li, Chenxi
Zhao, Chengxue
Tang, Bo
Tang, B
Wang, Y
Li, C
Gu, Bing
Zhao, C
Bao, J
Bao, Jingfeng
Gu, B
Wang, Wayne
Source
Elsevier; Medline; PMC
abstract
Abstract The outbreak of Coronavirus Disease-2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has threatened health worldwide. As of the end of 2020, there were nearly 10 million confirmed cases and nearly 5 million deaths associated with COVID-19. Rapid and early laboratory diagnosis of COVID-19 is the main focus of treatment and control. Molecular tests are the basis for confirmation of COVID-19, but serological tests for SARS-CoV-2 are widely available and play an increasingly important role in understanding the epidemiology of the virus and in identifying populations at higher risk for infection. Point-of-care tests have the advantage of rapid, accurate, portable, low cost and non-specific device requirements, which provide great help for disease diagnosis and detection. This review will discuss the performance of different laboratory diagnostic tests and platforms, as well as suitable clinical samples for testing, and related biosafety protection. This review shall guide for the diagnosis of COVID-19 caused by SARS-CoV-2.
has issue date
2020-07-02
(
xsd:dateTime
)
bibo:doi
10.1016/j.cca.2020.06.045
bibo:pmid
32621814
has license
els-covid
sha1sum (hex)
d0989413983a773fd446319495b14d5b951894e2
schema:url
https://doi.org/10.1016/j.cca.2020.06.045
resource representing a document's title
Laboratory Diagnosis of Coronavirus Disease-2019 (COVID-19)
has PubMed Central identifier
PMC7329657
has PubMed identifier
32621814
schema:publication
Clin Chim Acta
resource representing a document's body
covid:d0989413983a773fd446319495b14d5b951894e2#body_text
is
schema:about
of
named entity 'early'
named entity 'journal'
named entity 'affect'
named entity 'READABILITY'
named entity 'ACCEPTANCE'
named entity 'AFFECT'
named entity 'ADDITION'
named entity 'ADDITIONAL'
named entity 'legal'
named entity 'This'
named entity 'metadata'
named entity 'formatting'
named entity 'typesetting'
named entity 'pertain'
named entity 'readability'
named entity 'nasopharyngeal'
named entity 'SNV'
named entity 'genomic sequences'
named entity 'RT-PCR'
named entity 'COVID'
named entity 'LOD'
named entity 'enterovirus'
named entity 'alveolar'
named entity 'IgG antibody'
named entity 'titer'
named entity 'nucleocapsid'
named entity 'saliva'
named entity 'saliva'
named entity 'sputum'
named entity 'SARS-CoV-2'
named entity 'secretion'
named entity 'genomes'
named entity 'upper respiratory tract'
named entity 'SARS-CoV-2'
named entity 'metatranscriptomic'
named entity '5.7'
named entity 'IgG'
named entity 'respiratory symptoms'
named entity 'thiol'
named entity 'virus'
named entity 'viruses'
named entity 'RT-PCR'
named entity 'SARS-CoV-2'
named entity 'coronavirus'
named entity 'SARS-CoV-2'
named entity 'sensitivity and specificity'
named entity 'COVID'
named entity 'Germany'
named entity 'antisense oligonucleotides'
named entity 'serological tests'
named entity 'virus'
named entity 'influenza viruses'
named entity 'reagent'
named entity 'China'
named entity 'serology tests'
named entity 'biosensor'
named entity 'LOD'
named entity 'viral load'
named entity 'gene'
named entity 'COVID-19'
named entity 'neutralizing antibody'
named entity 'SARS-CoV-2'
named entity 'serum or plasma'
named entity 'United States'
named entity 'IgG'
named entity 'primers'
named entity 'cytopathic effects'
named entity 'COVID'
named entity 'WHO'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 10
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software